Investment
Features
FeesSafety
Academy
More
Pluang+

Compare AES Corp (AES) vs Amylx Pharmaceuticals Inc (AMLX) Price & Performance

Amylx Pharmaceuticals IncTrade

Price performance (Past 24H)

Key statistics

AES Corp vs Amylx Pharmaceuticals Inc — how do they compare? AES Corp trades at $14.72 (market cap $10.49B), while Amylx Pharmaceuticals Inc trades at $23.65 (market cap $2.64B). The key difference: AES Corp is far larger — about 4× Amylx Pharmaceuticals Inc's market cap, and AES Corp pays a 4.79% dividend while Amylx Pharmaceuticals Inc pays none. Which is the better fit depends on your goals.

AESAMLX
Market Cap
$10.49B$2.64B
Sector
UtilitiesHealth
52-Week High
$17.28$24.19
52-Week Low
$12.51$7.82
Enterprise Value
$40.75B$2.39B
Dividend Yield
4.79%

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About AES Corp

AES is a global power company operating across 14 countries and 4 continents. Its current generation portfolio as of year-end 2021 consists of over 31 gigawatts of generation, with the generation mix composed of renewables (43%), gas (32%), coal (23%), and oil (2%). The company has 3.5 gigawatts of generation under construction. AES has majority ownership and operates six electric utilities distributing power to 2.6 million customers.

Read more on AES

About Amylx Pharmaceuticals Inc

Amylyx Pharmaceuticals is a biopharmaceutical firm focused on developing therapies for rare diseases. Its pipeline includes treatments for conditions like post-bariatric hypoglycemia and congenital hyperinsulinism.

Read more on AMLX